Ovid Therapeutics Inc.·4

Apr 12, 5:34 PM ET

Rona Jeffrey A 4

4 · Ovid Therapeutics Inc. · Filed Apr 12, 2022

Insider Transaction Report

Form 4
Period: 2022-04-08
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-04-08+194,399194,399 total
    Exercise: $3.22Exp: 2032-04-07Common Stock (194,399 underlying)
  • Award

    Stock Option (Right to Buy)

    2022-04-08+10,00010,000 total
    Exercise: $3.22Exp: 2032-04-07Common Stock (10,000 underlying)
Footnotes (2)
  • [F1]The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable on October 8, 2022 and the remaining shares will vest in 18 equal monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.
  • [F2]The option shall vest as follows: 25% of the shares subject to the option will vest and become exercisable on April 8, 2023 and the remaining shares will vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous services through such vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION